BPC157.now
News & Research

BPC-157 news desk

Real updates, not rumors. Editorial summaries of regulatory developments and research — without marketing language. We cover the formal FDA process around BPC-157 as it happens.

After the PCAC Vote: The Full Road from Advisory Recommendation to Legal Compounding
Regulatory
Jun 10, 2026

After the PCAC Vote: The Full Road from Advisory Recommendation to Legal Compounding

A PCAC vote on July 23, 2026 is one step — not the finish line. This is a plain-language walkthrough of what happens after an advisory recommendation and how long the full process takes.

Read article
BPC-157 vs PDA+ Pentadeca Arginate: Key Differences, Current Status & What to Watch
Education
Jun 2, 2026

BPC-157 vs PDA+ Pentadeca Arginate: Key Differences, Current Status & What to Watch

A balanced, educational comparison of BPC-157 and PDA+ Pentadeca Arginate — distinct compounds with different regulatory profiles, research visibility, and availability pathways.

Read article
How the FDA 503A Bulks List Works: A Plain-Language Explainer
Education
May 20, 2026

How the FDA 503A Bulks List Works: A Plain-Language Explainer

The 503A bulks list determines which substances licensed compounding pharmacies can legally use. Understanding how it works is essential context for the July 2026 BPC-157 PCAC review.

Read article
FDA Schedules 2026 Review of BPC-157-Related Compounding Substances
Regulatory
May 14, 2026

FDA Schedules 2026 Review of BPC-157-Related Compounding Substances

The FDA has placed BPC-157-related substances on the July 2026 Pharmacy Compounding Advisory Committee (PCAC) agenda, signaling a formal review of their place in U.S. compounding.

Read article
What Is the FDA Pharmacy Compounding Advisory Committee (PCAC)?
Education
May 5, 2026

What Is the FDA Pharmacy Compounding Advisory Committee (PCAC)?

The PCAC is the FDA advisory committee reviewing BPC-157 in July 2026. Here is how it works, who is on it, and why its recommendation matters — but is not final.

Read article
Is BPC-157 FDA Approved? Current U.S. Status Explained
Regulatory
Apr 28, 2026

Is BPC-157 FDA Approved? Current U.S. Status Explained

Short answer: no. BPC-157 is not FDA approved. Here is a plain-language explanation of what that actually means and what the current U.S. status looks like.

Read article
What the July 2026 FDA Advisory Meeting Could Mean for BPC-157
Regulatory
Apr 10, 2026

What the July 2026 FDA Advisory Meeting Could Mean for BPC-157

An educational walkthrough of the possible outcomes of the July 23, 2026 PCAC meeting on BPC-157-related substances — and why none of them mean instant access.

Read article
Why BPC-157 Regulatory Changes Matter for Consumers
Education
Mar 22, 2026

Why BPC-157 Regulatory Changes Matter for Consumers

Regulatory framing determines quality, oversight, and safety signals for any substance. Here is why the BPC-157 rulemaking process matters beyond the headlines.

Read article
BPC-157 Research: What Consumers Should Know Before Making Decisions
Research
Feb 18, 2026

BPC-157 Research: What Consumers Should Know Before Making Decisions

An editorial look at the state of BPC-157 research — where the evidence comes from, what it does and does not show, and why consumers should talk to licensed professionals.

Read article
Free Updates

New articles go to subscribers first.

Regulatory updates and research context, delivered when we publish — not days later.

BPC157.now does not sell, prescribe, or dispense BPC-157. Informational only.

Get Free BPC-157 Updates